| Item Type | Name |
|
Academic Article
|
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
|
|
Academic Article
|
Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine.
|
|
Academic Article
|
Neurologic presentation of Wilson disease without Kayser-Fleischer rings.
|
|
Academic Article
|
Botulinum toxin in clinical practice.
|
|
Academic Article
|
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
|
|
Academic Article
|
Progressive supranuclear palsy: motor, neurobehavioral, and neuro-ophthalmic findings.
|
|
Academic Article
|
Treatment of advanced Parkinson's disease.
|
|
Academic Article
|
Disease-oriented approach to botulinum toxin use.
|
|
Academic Article
|
Atomoxetine for freezing of gait in Parkinson disease.
|
|
Academic Article
|
Occupation and risk of parkinsonism: a multicenter case-control study.
|
|
Academic Article
|
Peripheral trauma and movement disorders: a systematic review of reported cases.
|
|
Academic Article
|
Hemiballism-hemichorea. Clinical and pharmacologic findings in 21 patients.
|
|
Academic Article
|
How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale.
|
|
Academic Article
|
A comparison of postspace-flight orthostatic intolerance to vasovagal syncope and autonomic failure and the potential use of the alpha agonist midodrine for these conditions.
|
|
Academic Article
|
What is it? Case 1, 1993: parkinsonism, dysautonomia, and ophthalmoparesis.
|
|
Academic Article
|
Effects of pallidotomy on gait and balance.
|
|
Academic Article
|
Acoustic reflex abnormalities in cranial-cervical dystonia.
|
|
Academic Article
|
Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial.
|
|
Academic Article
|
Tardive gait.
|
|
Academic Article
|
Clinical aspects of progressive supranuclear palsy.
|
|
Academic Article
|
Camptocormia, head drop and other bent spine syndromes: heterogeneous etiology and pathogenesis of Parkinsonian deformities.
|
|
Academic Article
|
Respiratory problems in neurologic movement disorders.
|
|
Concept
|
Heredodegenerative Disorders, Nervous System
|
|
Concept
|
Nervous System Diseases
|
|
Concept
|
Autonomic Nervous System Diseases
|
|
Concept
|
Gait Disorders, Neurologic
|
|
Concept
|
Peripheral Nervous System Diseases
|
|
Academic Article
|
The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond.
|
|
Academic Article
|
Neurohistopathological findings at the electrode-tissue interface in long-term deep brain stimulation: systematic literature review, case report, and assessment of stimulation threshold safety.
|
|
Academic Article
|
Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders.
|
|
Academic Article
|
Genetics and molecular biology of brain calcification.
|
|
Academic Article
|
Botulinum toxin: State of the art.
|
|
Academic Article
|
The Wide Spectrum of Functional Movement Disorders.
|
|
Academic Article
|
Functional gait disorders, clinical phenomenology, and classification.
|
|
Academic Article
|
Outcome measurement in functional neurological disorder: a systematic review and recommendations.
|
|
Academic Article
|
Understanding the relationship between freezing of gait and other progressive supranuclear palsy features.
|
|
Academic Article
|
Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity.
|
|
Academic Article
|
Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approach.
|
|
Academic Article
|
Spinal cord stimulation for gait disturbances in Parkinson's disease.
|